Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02695043 · ClinicalTrials.gov registry record · NA
MMEPT for Traumatic Brain Injury
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT02695043: Completed NA study, sponsored by NYU Langone Health.
NCT02695043 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02695043, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The primary purpose of this research is to increase adherence to outpatient rehabilitation of chronically underserved individuals with traumatic brain injury (TBI). The intervention will be a TBI rehabilitation-focused education tool suitable for use with a wide variety of patients, including those with poor literacy skills and those with Limited English Proficiency (LEP), hereafter referred to as the Multimedia Multicultural Educational Program for TBI (MMEPT).
Interventions
- BEHAVIORAL RRTBIMS
- BEHAVIORAL Multimedia Multicultural Educational Program for TBI (MMEPT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2016-03 |
| Est. Completion | 2019-07-05 |
| Phase | NA |
What the finished NCT02695043 record still lists
NCT02695043 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which RRTBIMS is the first listed.
NCT02695043 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02695043 about?
NCT02695043 is a clinical study titled "MMEPT for Traumatic Brain Injury". The primary purpose of this research is to increase adherence to outpatient rehabilitation of chronically underserved individuals with traumatic brain injury (TBI). The intervention will be a TBI rehabilitation-focused education tool suitable for use with a wide variety of patients, including those ...
What is the current status of trial NCT02695043?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2016-03. Estimated completion is 2019-07-05.
What interventions are being tested in trial NCT02695043?
The interventions under investigation include: RRTBIMS (BEHAVIORAL), Multimedia Multicultural Educational Program for TBI (MMEPT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02695043?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02695043's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia